United Kingdom · Question · Written question
UIN 5800
Metachromatic Leukodystrophy
Introduced
1 June 2026
Last action
1 July 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
1 July 2026
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of adding metachromatic leukodystrophy (MLD) to the NHS newborn blood spot screening programme.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 June 2026
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of adding metachromatic leukodystrophy (MLD) to the NHS newborn blood spot screening programme.
Source: Commons
1 July 2026
Answer
Members of the UK National Screening Committee (UK NSC) have agreed that metachromatic leukodystrophy (MLD) would be a good candidate for the inclusion in a multi-condition in-service evaluation (ISE) within the United Kingdom’s newborn blood spot (NBS) s...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-06-01/5800
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1910893
- uk · wq-1910893 · source updated 1 July 2026